Up to a third of older people who fall are taking prescribed anticoagulants at the time of the incident. This article provides guidance on imaging decisions and anticoagulation management in suspected and confirmed traumatic brain injury www.bmj.com/content/389/...

What are the barriers to recruitment and participation in RCTs evaluating postpartum thromboprophylaxis? This qualitative study reveals trust in providers, altruism, and risk perception as key motivators and barriers. Important insights for future trial design. www.jthjournal.org/article/S153...

🩸 We're supporting #NHSBloodDonation this #NationalBloodWeek. A million regular donors are needed to meet demand and help patients in need. If you're the giving type, make it count by becoming a lifesaving blood donor. Find out more ➡️ bit.ly/3RxPf8N #NationalBloodWeek25 #GiveBlood

New review discusses underutilization of effective agents for hematologic care. The team, including @heme-fan.bsky.social and @gbarnesmd.bsky.social recommend addressing this knowledge gap with better patient education resources! www.rpthjournal.org/article/S247...

@emanhassan.bsky.social Congratulations!

📢 New in Lancet Haematology! Our commentary explores how machine learning can personalise blood donation by predicting ferritin recovery—not just haemoglobin. Towards safer, iron-aware donation practices. doi.org/10.1016/S235... #Haematology #BloodDonation #DigitalHealth

Have you had a blood clot and would like to get involved with research? Take a look at our news update - lots of opportunities seeking your voice conta.cc/4dLqMa2

Interested in pregnancy-associated VTE? Do you use the RCOG GTG 37a? Here's a commentary @bjog.bsky.social from the guideline update committee. doi.org/10.1111/1471... @isth.org @bhwords.bsky.social @profmakris.bsky.social @middeldorps.bsky.social @fniainle.bsky.social @laranroberts1.bsky.social

Excellent review. www.nature.com/articles/s41...

👥 Meet the future of thrombosis and hemostasis research. In "Leading from the Start", we highlight the pivotal role of the ISTH SSC and its Early Career Co-Chairs—emerging leaders who are already making a global impact. Read more here: bit.ly/3XOmNCI

Congratulations to the 2025 Editor’s Awards Recipients! We invite the community to read and share their important contributions ⬇️

Prof. @isabellemahe.bsky.social presents API-CAT at @accintouch.bsky.social published in @nejm.org: Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose for preventing recurrent VTE, with less clinically relevant bleeding 🩸in cancer patients www.nejm.org/doi/full/10....

Countries that have issued a travel advisory this year warning their citizens about visiting the United States: Canada Denmark Finland France Germany Ireland Netherlands New Zealand United Kingdom

📢 @jthjournal.bsky.social is proud to announce the recipients of the 2025 JTH Editors’ Awards! These prestigious awards honor six outstanding early career investigators for their top articles in thrombosis and hemostasis. Join us in congratulating the winners🎉 and learn more here: bit.ly/4lc2pFR

If you are interested in vascular liver diseases , you are definitively interested in joining this COST Action!

Brexit a key factor in worst UK medicine shortages in four years, report says www.theguardian.com/society/2025...

Very sad. So many good doctors driven to either leaving the NHS or taking their own lives.

The Repeat Study addressed a really important knowledge gap! The incidence of recurrent events following an ante- or postpartum VTE is 2.4% person-years. The cumulative risks are 6%, 13%, 17%, and 30% at 2, 5, 10, and 30 years respectively www.jthjournal.org/article/S153... @jthjournal.bsky.social

stoptrump.org.uk/petition-can... obvs right?

Read this State of The Art review on transfusion therapy in trauma first presented at the @isth.org 2024 Congress: Transfusion in trauma: empiric or guided therapy? Full paper here: www.rpthjournal.org/article/S2475-0379(24)00358-3/fulltext

As promised, here are the slides I shared with students to convince them to NOT use chatGPT and other artificial stupidity. TL;DR? AI is evil, unsustainable and stupid, and I'd much rather they use their own brains, make their own mistakes, and actually learn something. 🪄

Large international multicenter cohort study showing that DOACs are a good option to treat cerebral venous thrombosis. Kudos to @jonathancoutinho20.bsky.social and team for pulling this off! authors.elsevier.com/c/1ke765FFzL...

@nytimes.com positions let go

Did you know? Around 50% of patients with acute CAT in your practice do not meet the inclusion criteria of the RCTs. Listen to the podcast with @gbarnesmd.bsky.social about recent trials taking a more pragmatic approach. www.medthority.com/medical-educ...

If you're looking for #PsychologicalSafety in academia, this is how it's done- 👏👏👏 to Bond University medical program for recognising effort as much as achievement with awards like the 'Sorry, Try Again Award'. 11 rejections, woohoo! 🤣❤️

Introducing JTH’s new Educational Review Series—your go-to resource for fundamental insights into critical topics in thrombosis and hemostasis ⬇️

Censor CDC scientists and ask them to withdraw papers from medical journals? This is not how it works, Mr President. Our response @bmj.com on the Trump Executive Order and his "forbidden words" www.bmj.com/content/388/...

Join us in planning the 2026 ISTH Congress in Paris!!

Pulmonary embolism (PE) diagnosis 🫁: 🔹 Different D-dimer assays = big impact on CT usage & yield. 🔹 Standardized assays or tailored cutoffs could reduce unnecessary scans and improve accuracy. Find out which assays were tested here: https://buff.ly/4hcXDoF

Congratulations Elena Butera for receiving the 2025 @isth-official.bsky.social INVENT-VTE Fellowship! Read more at https://buff.ly/4hp9iAB to learn about Elena's journey & how you could benefit from one of the many Fellowships & other grants ISTH provides to support #ISTHearlycareer professionals!

Please repost if you agree with Ursula.

A new editorial describes the science behind a clinical trial reported by Ruff et al. in which a monoclonal antibody targeting factors XI and XIa was evaluated for its effects on bleeding events in patients with atrial fibrillation. Read the full editorial: nej.md/3Eg76gw #MedSky #ScienceSky

The best time to stop using Amazon was probably a few years ago, but the second best time is now.

My favorite Sankey diagram 😍 After one VTE recurrence, the main issue is ... another VTE recurrence ! @rpth.bsky.social @isth-official.bsky.social

THE Louise China is co-author

Publication alert 📣! How to prevent #postpartum #VTE in women at moderate risk? Outcomes of the PILOTPARTUM pilot have been published in Lancet Hematology. Kudos to Dr Leslie Skeith and all passionate colleagues, and to all women who participated! www.sciencedirect.com/science/arti...

This is your chance to shape the field of #thrombosis and #hemostasis. Apply for editorial positions at @isth-official.bsky.social journals @RPTH.bsky.social - Assoc. Editor (2x) @JTHjournal.bsky.social - Early Career Assoc. Editor (1x) Deadline is Jan 30! Apply here 👇 https://buff.ly/3BRloDM

We report 0.9% VTE within 90 days of hospital led acute ambulatory care attendance; similar to traditional medical inpatient care without thromprophylaxis. Further VTE research needed in this rapidly expanding area of medicine#VTE#SDEC @danlasserson.bsky.social www.sciencedirect.com/science/arti...

Library purchases are purchases. They pay the press. The press counts them towards advances and royalties. And (gasp) the book is in a library!! It’s wonderful and no one should ever feel bad about getting a book through a library instead of buying it.

I want to thank Elon Musk for attacking Wikipedia for being a part of the internet he can't currently control. It reminded me to donate to support Wikipedia, the best remaining thing about the internet. You can donate here: donate.wikimedia.org/w/index.php?...

👀 🚨 FDA denies full approval of Andexanet Can’t say I am surprised. It will be interesting to see what happens next #SkyRx #PharmSky #CardioSky #HemeSky firstwordpharma.com/story/5921956

📢 New Report Alert: National State of Patient Safety 2024. The latest report from the Institute of Global Health Innovation offers vital insights into the current challenges facing the NHS. This report sheds light on critical issues impacting healthcare in England: www.imperial.ac.uk/Stories/Nati...

After highlighting the steep rise in alcohol-related liver disease in young women, we now highlight an even bigger problem in our children. The highest prevalence of lifetime alcohol use for 11-year-olds (34% girls) was observed in the UK. @Inst_of_Liver doi.org/10.1016/j.jhep.2024.12.010 #liversky

Oral HRT increases venous thrombotic risk (VTE). Tibolone increases arterial but not VTE risk. Topical HRT showed no increase in either. Huge prospective Swedish study: 919,614 women of whom 77,512 started HRT. tinyurl.com/85jxatux #HRT

You can read the TREATT results out now in Lancet Haem: www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00317-X/abstract Great collaboration with @liseestcourt.bsky.social, Simon Stanworth and teams at NHSBT & Monash TRU. Thanks to all participants, and NHMRC & ANZSBT for supporting us!

✨BIG NEWS!✨The ISTH is thrilled to announce the 2026 Congress will be in Paris, France! Join thousands of global experts in thrombosis & hemostasis for a week of cutting-edge science, collaboration, and innovation 📅: July 11-15, 2026 📍: Paris Expo Porte de Versailles bit.ly/3BaAwf3 #ISTH2026 #ASH24

Paper in this week's NEJM shows that in patients with atrial fibrillation and stable coronary artery disease, edoxaban monotherapy is superior to the combination of edoxaban plus an antiplatelet drug. Major difference was in bleeding rather than reduction in ischaemic events.

Congratulations to the Irish #TILLIRI investigators, led by Dr Denis O'Keefe! In a large observational study incl. people with lower limb injury & immobilization, VTE occurrence at 90 days was low. #medsky #hemesky #INViTEresearch @jthjournal.bsky.social www.sciencedirect.com/science/arti...

You can do this even if you're not in the US. (And can donate to a non-US organization.) #Meal-ioidosis could use your help right now. 😊 #HCWvsHunger #IDSky #Clinmicro #MedSky #EpiSky

The GMC Workforce Report 2024 is a sobering read- one FIFTH of surgeons and >1/4 ophthalmologists leave within 5 years of joining the specialist register. Even in the best specialty, ED, it's >1/10. That's especially concerning considering recent NHS data linking staff turnover and patient mortality